Hepatitis Flashcards
1
Q
*Lamivudine, *tenovir. (+Entecavir)
A
Hepatitis -Nucleoside/nucleotide analogs -focused on Hep B Lamivudine -Therapeutic Indication -Chronic HBV -HIV Tenofovir -Therapeutic Indication -Chronic HBV -Pharmacokinetics -Oral bioavailability 25% fasting – *39% high-fat meal ADE lamivudine -Headache, nausea, dizziness tenofovir -HA and *asthma (caution in pts w/ renal dysfx), GI complaints
2
Q
*Pegylated interferon 2a; 2b
A
Hepatitis -Interferon Alpha -focused on Hep B -*dose reduced for pts w/ renal insufficiency Therapeutic indication -Hepatitis C (and B apparently) -HBV MOA -Stimulate Interferon receptors = degradation of host/viral RNA and protein synthesis -Degradation of viral/host mRNA -Inhibit viral/host protein synthesis ADE -*flu-like sx, *neurotoxicity, *myopathy, neutropenia
3
Q
Ribavirin
A
Hepatitis -focused on Hep C Therapeutic -HCV -RSV -*Not a monotherapy used with other antivirals (PEG INF, Sofosbuvir) MOA -*Interfere with GTP synthesis -*Inhibit RNA dependent polymerase -Inhibit capping of viral mRNA -*Ribavirin Triphosphate (RTP) inhibits replication: -Influenza, RSV, HIV, HCV ADE -*hemolytic anemia Contraindication -*pregnancy due to teratogenoic effects
4
Q
*Simeprevir
A
Hepatitis
-focused on Hep C
Therapeutic
-HCV: used in combination of PEG INF + Ribavirin or Sofosbuvir
MOA
-Inhibitor of HCV NS3/4A serine protease, important for viral replication
ADE
-*rash, photosensitivity, pruritus, nausea
Contraindications
-Associated with other antivirals apply to Simeprevir
5
Q
*Sofobuvir
A
Hepatitis *Polymerase inhibitor -focused on Hep C Therapeutic -HCV used in *combination with (simeprevir, ribavirin, or ribavirin + PEG INF) MOA -Nucleotide analog HCV NSB5 -RNA dependent RNA ADE (depends on combo) -+ ribavirin ( fatigue and headache) -+ PEG INF (fatigue, headache, nausea, insomnia, and anemia) Contraindications -Associated with other antivirals apply (*patients negative pregnancy test before initiation)
6
Q
*Harvoni, *Sofosbuvir+Ledipasvir
A
Hepatitis -focused on Hep C -\$\$$ Therapeutic -HCV MOA -HCV NS5A inhibitor ADE -fatigue, HA
7
Q
Lactulose
A
Liver dysfx -osmotic laxative Therapeutic -used in hepatic encephalopathy -reduces blood ammonia levels MOA -Reduction of fecal pH, leading to reduced blood ammonia. -ammonia that diffuses into gut is "trapped" and excreted in poop (NH3-->NH4) *"ION TRAPPING" -suppress urease producing organism -causes an osmotic type of laxation with diminishes fecal stasis ADE -excessive sweet taste -GI upset -hypernatremia